In addition, some countries do not distinguish between distribution within the Union and import/export from/to third countries which may be considered an important hurdle, not only against data collection and analysis, but also against optimal circulation of tissues and cells for patient benefit across the EU.
Esto puede considerarse un obstáculo importante, no solo para la recogida y el análisis de los datos, sino también para la circulación óptima de tejidos y células en beneficio de los pacientes de toda la UE.